Month: May 2020

L’essai eNRGy de phase 1/2 du MCLA-128 (zenocutuzumab reste) sur la bonne voieMise à jour du programme MCLA-117 qui sera présenté lors du prochain congrès médicalAnand Mehra, M.D. doit succéder à Russell Greig, Ph.D. au poste de président et Paolo Pucci a été désigné pour être nommé au conseil d’administration de MerusUTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 13 mai 2020 (GLOBE NEWSWIRE) — Merus NV (Nasdaq : MRUS) (« Merus », la « Société », « nous » ou « notre »), une société d’oncologie au stade clinique qui développe des anticorps multispécifiques de pleine longueur innovants (Biclonics® et Triclonics™), a annoncé aujourd’hui ses résultats financiers pour le premier trimestre clos le 31 mars 2020 et a fait le point sur ses activités.« Nous avons progressé dans nos programmes cliniques malgré les effets...

MCLA-128, Zenocutuzumab, eNRGy-Studie der Phase I/II bleibt im ZeitplanUpdate zum MCLA-117-Programm wird auf bevorstehender medizinischer Tagung präsentiertAnand Mehra, M.D. tritt Nachfolge von Russell Greig, Ph.D. als Vorsitzender an und Paolo Pucci ist für die Berufung in den Vorstand von Merus nominiertUTRECHT, Niederlande, und Cambridge, Mass., May 13, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) („Merus“, die „Gesellschaft“, „wir“ oder „unser“), ein Unternehmen aus dem Bereich der klinischen Onkologie, das innovative multispezifische volllange Antikörper (Biclonics® und TriclonicsTM) entwickelt, gab heute die Finanzergebnisse für das erste Quartal zum 31. März 2020 bekannt und legte ein Update zur Geschäftsentwicklung vor.„Wir haben trotz der Auswirkungen der aktuellen COVID-19-Pandemie Fortschritte bei unseren klinischen...

SANTA MONICA, Calif., May 13, 2020 (GLOBE NEWSWIRE) — SUPER LEAGUE GAMING, INC. (NASDAQ: SLGG) (“Super League Gaming” or the “Company”), a global leader in competitive video gaming and esports entertainment for everyday players around the world, today announced it has entered into securities purchase agreements with institutional investors for the purchase and sale of 1,825,000 shares of common stock, par value $0.001 per share at an offering price of $3.50 per share, pursuant to a registered direct offering, priced at-the-market under Nasdaq rules. The gross proceeds of the offering will be approximately $6,387,500 before deducting fees and other estimated offering expenses. The closing of the registered direct offering is expected to take place on or about May 15, 2020, subject to the satisfaction of customary closing conditions.A.G.P./Alliance...

 Schlieren/Switzerland, 13 May 2020AttachmentShareholderNotification_May13

 Schlieren/Switzerland, 13 May 2020The Board of ARYZTA announces that in April it appointed Rothschild & Co to under­take a review of all strategic and financial options available to the Group to maximise value for the benefit of all of the Group’s stakeholders. The review is expected to be concluded by the end of July 2020.   AttachmentAdhoc_20200513

BEIJING, CHINA, May 13, 2020 (GLOBE NEWSWIRE) — China Liberal Education Holdings Limited (Nasdaq: CLEU) (“China Liberal”), an educational services provider in China, today announced the closing of its initial public offering (“IPO”) of 1,333,333 ordinary shares priced at $6.00 per ordinary share, before underwriting discounts and offering expenses, resulting in gross proceeds of $8,000,000. The offering was conducted on a firm commitment basis and closed on May 12, 2020.The ordinary shares were previously approved for listing on The Nasdaq Capital Market and commenced trading under the ticker symbol “CLEU” on May 8, 2020.Boustead Securities, LLC (“Boustead”), acted as the sole underwriter for the offering, with Zinvest Global Limited in Hong Kong serving as Asian book runner. Hunter Taubman Fischer & Li LLC acted as counsel...

GERMANTOWN, Md., May 13, 2020 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a pioneering global biotech company committed to accelerating commercialization and transforming the delivery of cell and gene therapies (CGTs) while lowering costs, today announces the launch of its new cell-based vaccine platform targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, as well as other viral diseases such as Zika, West Nile Virus, Yellow Fever, Dengue Fever, MERS, HCV and Cytomegalovirus infection (CMV).The Company has been working aggressively the last few months to repurpose its cell-based vaccine platform targeting solid tumors for use against viral diseases.  The cell-based vaccine platform utilizes irradiated permissive cells (human or non-human, infected...

TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — O3 Mining Inc. (TSX.V:OIII) (“O3 Mining” or the “Corporation”) is pleased to announce it will resume exploration activities on it’s Val D’Or properties following an announcement from the Government of Quebec, which eases restrictions previously in place due to COVID-19.Consistent with past practice, the Company’s priority in this resumption will be the health and safety of its employees and contractors, their families, and communities in which we operate.  The company is applying the recommendations that the National Institute of Public Health of Quebec (INSPQ) and the CNESST have published for preventive measures as well as a guide to sanitary standards for the mining sector. Personnel will be subject to heightened health and safety standards in accordance with precautions...

New York, May 13, 2020 (GLOBE NEWSWIRE) —  Interpublic Group (NYSE: IPG) announced today that it has joined a coalition of more than 90 companies and NGO partners to respond to issues of diversity and inclusion surrounding COVID-19 with specific denouncement of anti-Asian sentiment and an awareness of the disease’s unique impacts upon vulnerable groups. Led by Ascend, the NGO partners also include ALPFA, Catalyst, The Conference Board, Management Leadership for Tomorrow (MLT), National Association of Black Accountants (NABA), National Congress of American Indians (NCAI), National Organization on Disability (NOD), Out & Equal, and Tanenbaum. This coalition has adopted a five-point action agenda that includes:Promoting Inclusion: Advocate for a diverse and inclusive workplace and societyRaising Awareness: Highlight the unique impacts...

SASKATOON, Saskatchewan, May 13, 2020 (GLOBE NEWSWIRE) — GESPEG RESOURCES LTD. (TSX-V:GCR) (the “Company” or “Gespeg”), announces that it is proposing to extend the expiry dates and alter the exercise price of certain share purchase warrants (the “Warrants“).  1,365,000 Warrants were issued on May 31, 2018 and 573,333 Warrants were issued on June 14, 2018 as part of a private placement that closed in two tranches.  The Warrants are exercisable into common shares in the capital of the Company (the “Shares”) at a price of 0.30 ($0.06 pre consolidation) per Share and will expire on May 31 and June 14, 2020.  No warrants have been exercised to date.Subject to the approval of TSX Venture Exchange (“TSX-V“), Gespeg will extend the expiration of these Warrants to May 31 and June 14, 2021 and lower the exercise price...